Ricolinostat (acy-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via mir-30d/pi3k/akt/mtor and erk pathways

HIGHLIGHTS

• who: Jinlin Cao from the In total, human ESCC specimens were collected in the Department of Thoracic Surgery, First Affiliated Hospital, College of Medicine, Zhejiang University, between June , and October Written informed consent was obtained from all patients before the specimens were collected and the study protocol was approved by the institutional ethical review board. Survival time was calculated from the date of diagnosis have published the research work: Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways, in the Journal: (JOURNAL) of July . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.